Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Piqray

02 1Piqray/Vijoice

PharmaCompass

01

Brand Name : Piqray

Alpelisib

arrow
Antibody Engineering
Not Confirmed

Brand Name : Piqray

arrow
Antibody Engineering
Not Confirmed

Alpelisib

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 320

2019 Revenue in Millions : 116

Growth (%) : 176

blank

02

Brand Name : Piqray

Alpelisib

arrow
Antibody Engineering
Not Confirmed

Brand Name : Piqray

arrow
Antibody Engineering
Not Confirmed

Alpelisib

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 329

2020 Revenue in Millions : 320

Growth (%) : 3

blank

03

Brand Name : Piqray

Alpelisib

arrow
Antibody Engineering
Not Confirmed

Brand Name : Piqray

arrow
Antibody Engineering
Not Confirmed

Alpelisib

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 373

2021 Revenue in Millions : 329

Growth (%) : 13

blank

04

Brand Name : Piqray/Vijoice

Alpelisib

arrow
Antibody Engineering
Not Confirmed

Brand Name : Piqray/Vijoice

arrow
Antibody Engineering
Not Confirmed

Alpelisib

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 505

2022 Revenue in Millions : 373

Growth (%) : 35

blank

05

Brand Name : Piqray

Alpelisib

arrow
Antibody Engineering
Not Confirmed

Brand Name : Piqray

arrow
Antibody Engineering
Not Confirmed

Alpelisib

Main Therapeutic Indication : Oncology

Currency : USD

2019 Revenue in Millions : 116

2018 Revenue in Millions : 0

Growth (%) : New launch

blank